U.S. Biotech Stock News

In April 2026, Shake Shack Inc. launched Project Catalyst, a broad technology push to modernize restaurant systems, build its first loyalty program, expand AI tools, and strengthen data capabilities as it works toward 1,500 Company-operated Shacks. By partnering with cloud-native platform Qu to overhaul its POS and kitchen display systems, Shake Shack is betting that better data, faster ordering, and AI-driven insights can tighten operations while deepening guest engagement across both...

Why Perdoceo Education Is On Investors’ Radar Perdoceo Education (PRDO) has drawn fresh attention after a period of solid share price movement, with returns over the past month and past 3 months outpacing its longer term performance profile. See our latest analysis for Perdoceo Education. The recent momentum looks strong, with a 10.29% 1 month share price return and 20.17% 3 month share price return feeding into a 30.41% year to date share price return and a 52.79% 1 year total shareholder...

What Assured Guaranty’s Recent Performance Tells Investors Assured Guaranty (AGO) has drawn fresh attention after a period where the share price showed a 4.3% decline over the past month and a 9.1% decline over the past 3 months, inviting a closer look at current valuation and fundamentals. See our latest analysis for Assured Guaranty. While the recent 30 day and 90 day share price returns of 4.3% and 9.1% declines suggest fading momentum in the short term, the 1 year and 5 year total...

In early April 2026, Sun Cruiser, part of Boston Beer Company, launched its Sun Cruiser White Tea + Vodka line across select U.S. states, offering a non‑carbonated, low‑calorie, vodka-based ready-to-drink variety pack in four white tea-inspired flavors. This move highlights Boston Beer’s push into “better-for-you,” non-carbonated spirits-based RTDs, an area where differentiation and early brand recognition can be important for long-term consumer traction. We’ll now examine how this...

Paramount Skydance (NasdaqGS:PSKY) has secured nearly US$24b in equity commitments from sovereign wealth funds in Saudi Arabia, Qatar, and Abu Dhabi. The company is restructuring its capital for the planned Warner Bros. Discovery acquisition, including an increase in authorized Class B shares. Existing shareholders are set to receive long-dated Nasdaq traded warrants, with additional equity syndicated to institutional investors. For you as an investor, this move sits at the crossroads of...

Pinnacle Financial Partners recently expanded its Louisville Lakeview office by hiring David Krebs, a veteran commercial banker with more than 25 years of relationship-management experience from Stock Yards Bank & Trust. At the same time, fresh analysis points to rising expenses, a relatively low 3.2% net interest margin and slowing tangible book value growth, prompting questions about how efficiently Pinnacle can convert its sizeable US$877.4 million net cash position into sustainable...

HCI Group recently reported a strong Q4, with revenues rising 52.1% year on year, beating analyst expectations and capping a year of record 2025 earnings and shareholder returns, alongside the successful IPO of its technology platform, Exzeo. The combination of rapidly growing revenue and the separation of Exzeo as a listed technology platform raises fresh questions about how HCI Group’s business mix and earnings profile could evolve. Next, we’ll examine how HCI Group’s record 2025 earnings...

Babcock & Wilcox Enterprises recently secured a US$2.40 billion design-build contract with Base Electron to deliver 1.2 gigawatts of natural gas-fired power generation for AI data center campuses, lifting its reported operations backlog to US$2.80 billion. The deal has positioned Babcock & Wilcox as a meaningful supplier to the fast-growing AI data center power market, while also drawing regulatory scrutiny over how the contract was structured and its implications for a major...

Wyndham Hotels & Resorts has recently reshaped its leadership team, appointing Amit Sripathi as Chief Financial Officer and David Wilner as Chief Development Officer – North America, while also marking expansion milestones such as surpassing 100 Trademark Collection hotels in the US and more than 100 properties across Mexico. Together, these leadership changes and portfolio milestones highlight Wyndham’s emphasis on disciplined franchise growth and deeper penetration in both domestic and key...

In 2025, former H2O America President, CEO, and Chairman Eric W. Thornburg received total compensation of US$3,065,270, while the current CEO recently sold shares on the open market and institutional investors shifted their holdings. At the same time, short interest in H2O America jumped very large in March, with a significant portion of shares now sold short, pointing to a sharper focus on potential operational or financial issues. Analyst Ross Fowler at BofA Securities continues to rate...

In early March 2026, Baldwin Insurance Group reported fourth-quarter 2025 earnings that exceeded analyst expectations despite a slight revenue shortfall, while director Paul Eugene Sparks purchased US$1,000,000 of Class A Common Stock and Raymond James upgraded its rating on the shares to Strong Buy. Taken together, the insider share purchase and analyst upgrade underscore growing confidence in Baldwin Insurance Group’s business quality and earnings resilience, even as revenue growth came in...

In recent weeks, Iris Energy (IREN) accelerated its pivot from Bitcoin mining to GPU-powered AI cloud services, securing over 50,000 Nvidia B300 GPUs and advancing plans to leverage a secured 4.5GW power portfolio for large-scale data center expansion. At the same time, a very large US$6.00 billion at-the-market equity program and new U.S. tariffs on AI chips have raised questions about dilution, hardware costs, and execution risk as the company targets an AI cloud-focused future. Now we’ll...

On March 26, 2026, Murphy USA announced that long-time finance executive Donald R. Smith, Jr. had been appointed permanent Senior Vice President, Chief Financial Officer and Treasurer, while also disclosing his compensation terms and related governance details. This leadership change highlights the board’s preference for continuity and internal expertise at a time when some shareholders are also pushing for greater influence over corporate governance. We’ll now examine how Smith’s elevation...

In March 2026, Bio-Techne expanded its COMET spatial biology portfolio with new SPYRE Focus Panels, SPYRE Amplification Kits, and upgraded HORIZON image analysis software to enhance automated, modular tissue analysis workflows from assay design through interpretation. This expansion deepens Bio-Techne’s footprint in high-content spatial biology by combining validated, modular antibody panels with seqLA-based signal amplification to help researchers extract richer insights from scarce tissue...

Why Regencell Bioscience Holdings (NasdaqCM:RGC) is in Focus Right Now Regencell Bioscience Holdings (NasdaqCM:RGC) has filed a US$500 million follow on equity offering of common stock as an at the market program, shortly after registering a shelf for its ordinary shares. See our latest analysis for Regencell Bioscience Holdings. The equity offering headlines come after a sharp shift in sentiment, with a 7 day share price return of 32.15% and a 30 day share price return of 32.03%, set against...

Turning Point Brands (TPB) is back in focus after reports that the FDA is delaying approvals for its nicotine pouch products, raising fresh questions around regulation, youth access, and future product launches. See our latest analysis for Turning Point Brands. The regulatory headlines have hit sentiment hard, with a 30 day share price return showing an 18.51% decline and a 90 day share price return showing a 27.63% decline, even after the recent 3.51% one day gain to US$74.69. However, the 1...

At the March 27–31, 2026 American Academy of Dermatology meeting in Denver, Kenvue’s Neutrogena, Aveeno, and Rogaine brands showcased new science-backed products, research on hydration, acne care, and sun protection, and educational initiatives for dermatology professionals and residents. The breadth of clinical data, including work on advanced UV filters like BEMT and skin-barrier-supportive formulations, highlights how Kenvue is tying product innovation directly to evolving dermatologist...

Nelnet, Inc. recently entered into a new Credit Agreement for a US$435 million unsecured line of credit maturing on March 31, 2031, while terminating its prior US$495 million facility that was due in 2026 and carried no outstanding balance at the time. This refreshed, long-dated borrowing capacity, backed by customary financial covenants and subsidiary guarantees, underscores the company’s emphasis on maintaining flexible funding for general corporate purposes. With this extended US$435...

Recently, HF Sinclair reported quarterly earnings of US$1.20 per share, very large above the consensus estimate of US$0.44, extending a multi-quarter pattern of outperforming analyst expectations. This repeated earnings outperformance has led analysts to grow more optimistic about the company’s near‑term profit potential, especially given its integrated refining and fuel production footprint. Building on this recent history of substantial earnings surprises, we’ll explore how strengthened...

In March 2026, ICON plc and Advarra announced a partnership to create a connected, “research-ready” site network that links ICON’s clinical trial solutions with Advarra’s widely used site technologies to reduce administrative friction, speed up study startup, and expand trial access globally. This collaboration gives ICON access to Advarra’s data and AI-driven operational intelligence, potentially refining protocol design, forecasting, and site selection by aligning studies more closely with...

At the 2026 American Academy of Dermatology meeting in Denver, Arcutis Biotherapeutics reported Phase 2 INTEGUMENT-INFANT data showing ZORYVE cream 0.05% improved signs and symptoms of mild to moderate atopic dermatitis in infants aged 3 to less than 24 months, with a safety and tolerability profile consistent with prior pediatric trials. Beyond reinforcing ZORYVE’s safety across very young patients, the new data underpin Arcutis’ plan to file a supplemental New Drug Application in 2026,...

Key performance context for PayPay PayPay (PAYP) has drawn attention after a 10.37% one day decline and an 8.81% drop over the past week, prompting investors to reassess its fundamentals and recent share price moves. The company reports annual revenue of ¥355,530 and net income of ¥111,208, with revenue growth of 16.82% and net income growth of 5.77% in the most recent year, all in its reporting currency. See our latest analysis for PayPay. The recent 10.37% one day share price return decline...

Why Maase Has Caught Investor Attention Recent trading interest in Maase (MAAS) has pushed the stock into focus, with short term performance and fundamentals prompting investors to reassess how this US listed China based financial services platform fits into their portfolios. See our latest analysis for Maase. At a share price of $5.90, Maase has seen a 7 day share price return of 8.26% and a 90 day share price return of 13.24%, suggesting recent momentum is building after a relatively modest...

CleanSpark (CLSK) is drawing fresh attention after approving a US$100 million bitcoin backed bond issue to fund data centers and power assets, a financing step aimed at expanding its bitcoin mining infrastructure. See our latest analysis for CleanSpark. The bitcoin backed bond announcement comes after a weaker patch for the shares, with a 90 day share price return of a 24.1% decline and a year to date share price return of a 21.21% decline, alongside a 1 year total shareholder return of...